Insufficient scRNA-seq data for expression of CARD17P at single-cell level.
Insufficient scRNA-seq data for expression of CARD17P at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 95% | 13.61 | 228 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 82% | 25.10 | 764 / 929 | 0% | 0 | 0 / 0 |
| lung | 46% | 4.19 | 266 / 578 | 28% | 0.85 | 324 / 1155 |
| esophagus | 37% | 11.89 | 536 / 1445 | 36% | 1.32 | 66 / 183 |
| skin | 66% | 17.97 | 1191 / 1809 | 7% | 0.13 | 33 / 472 |
| prostate | 38% | 3.05 | 93 / 245 | 1% | 0.03 | 5 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 38% | 0.86 | 17 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 0.72 | 10 / 29 |
| uterus | 3% | 0.59 | 5 / 170 | 30% | 1.09 | 137 / 459 |
| intestine | 23% | 2.73 | 222 / 966 | 7% | 0.14 | 37 / 527 |
| bladder | 5% | 2.52 | 1 / 21 | 16% | 0.66 | 80 / 504 |
| breast | 3% | 0.16 | 12 / 459 | 10% | 0.25 | 112 / 1118 |
| stomach | 6% | 0.38 | 21 / 359 | 5% | 0.10 | 15 / 286 |
| thymus | 7% | 0.64 | 44 / 653 | 2% | 0.04 | 14 / 605 |
| kidney | 6% | 0.62 | 5 / 89 | 2% | 0.04 | 17 / 901 |
| adipose | 7% | 0.49 | 84 / 1204 | 0% | 0 | 0 / 0 |
| liver | 4% | 0.15 | 8 / 226 | 1% | 0.03 | 5 / 406 |
| pancreas | 1% | 0.03 | 2 / 328 | 4% | 0.06 | 7 / 178 |
| ovary | 1% | 0.02 | 1 / 180 | 3% | 0.04 | 13 / 430 |
| blood vessel | 3% | 0.20 | 37 / 1335 | 0% | 0 | 0 / 0 |
| heart | 2% | 0.14 | 19 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 0.03 | 2 / 258 | 0% | 0.09 | 1 / 230 |
| brain | 1% | 0.03 | 19 / 2642 | 0% | 0.00 | 1 / 705 |
| muscle | 0% | 0.02 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
| GO_0089720 | Molecular function | caspase binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CARD17P |
| Protein name | Putative caspase recruitment domain-containing protein 17P (Caspase-1 inhibitor INCA) (Inhibitory caspase recruitment domain protein) |
| Synonyms | CARD17 INCA |
| Description | FUNCTION: Regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, do not induce NF-kappa-B activation. . |
| Accessions | Q5XLA6 |